Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 94Not yet recruiting 26Completed 21Active not recruiting 16Terminated 9Withdrawn 2Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 51Breast Neoplasms 40Colorectal Neoplasms 26Prostatic Neoplasms 22Lung Neoplasms 18Carcinoma, Non-Small-Cell Lung 15Carcinoma, Hepatocellular 15Stomach Neoplasms 14Hematologic Neoplasms 10Brain Neoplasms 10Pancreatic Neoplasms 9Colonic Neoplasms 9Urinary Bladder Neoplasms 8Lymphoma, Follicular 8Head and Neck Neoplasms 8Uterine Cervical Neoplasms 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Ovarian Neoplasms 7Melanoma 7Liver Neoplasms 7Leukemia, Myeloid, Acute 7Disease 7Anxiety Disorders 7Myasthenia Gravis 6Multiple Myeloma 6Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Rectal Neoplasms 5Lymphoma, Non-Hodgkin 5Lymphoma 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Advanced Solid Tumors × 1 year × Clear all
NCT07053904 2025-07-08

Phase I Open-Label Study of P1101 Followed by P1801 in Advanced Solid Tumors

PharmaEssentia

Phase 1 Enrolling by invitation
54 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡